Startup Behind AstraZeneca Covid-19 Vaccine Files for U.S. IPO

Vaccitech PLC, spun out of the University of Oxford in 2016, said it plans to use the technology underpinning the vaccine to develop treatments targeting prostate cancer, hepatitis B and human papillomavirus.

Meatpacking Industry Faces Overhaul Push in Washington

The push by lawmakers and regulators follows complaints about meat companies’...

Netflix Strikes Deal With Filmmaker Spielberg

Steven Spielberg’s production company, Amblin Partners, will make new films for...

Work Flexibility Is Hardly a Holy Grail

Surveys show many Americans aren’t eager to return to the office,...

Court Revives Challenge to California Mandate on Women Board Members

A federal appeals court said a shareholder may sue the state...